Daniel Alonso-Alconada1, Kevin D Broad1, Alan Bainbridge1, Manigandan Chandrasekaran1, Stuart D Faulkner1, Áron Kerenyi1, Jane Hassell1, Eridan Rocha-Ferreira1, Mariya Hristova1, Bobbi Fleiss1, Kate Bennett1, Dorottya Kelen1, Ernest Cady1, Pierre Gressens1, Xavier Golay1, Nicola J Robertson2. 1. From the Institute for Women's Health, University College London, London, United Kingdom (D.A.-A., K.D.B., M.C., S.D.F., A.K., J.H., E.R.-F., M.H., K.B., D.K., N.J.R.); Medical Physics and Bio-engineering, University College London Hospitals NHS Foundation Trust, London, United Kingdom (A.B., E.C.); Centre for the Developing Brain, King's College London, London, United Kingdom (B.F., P.G.); and Department of Brain Repair and Rehabilitation, Institute for Neurology, Queen Square, London, United Kingdom (X.G.). 2. From the Institute for Women's Health, University College London, London, United Kingdom (D.A.-A., K.D.B., M.C., S.D.F., A.K., J.H., E.R.-F., M.H., K.B., D.K., N.J.R.); Medical Physics and Bio-engineering, University College London Hospitals NHS Foundation Trust, London, United Kingdom (A.B., E.C.); Centre for the Developing Brain, King's College London, London, United Kingdom (B.F., P.G.); and Department of Brain Repair and Rehabilitation, Institute for Neurology, Queen Square, London, United Kingdom (X.G.). n.robertson@ucl.ac.uk.
Abstract
BACKGROUND AND PURPOSE: In infants with moderate to severe neonatal encephalopathy, whole-body cooling at 33°C to 34°C for 72 hours is standard care with a number needed to treat to prevent a adverse outcome of 6 to 7. The precise brain temperature providing optimal neuroprotection is unknown. METHODS: After a quantified global cerebral hypoxic-ischemic insult, 28 piglets aged <24 hours were randomized (each group, n=7) to (1) normothermia (38.5°C throughout) or whole-body cooling 2 to 26 hours after insult to (2) 35°C, (3) 33.5°C, or (4) 30°C. At 48 hours after hypoxia-ischemia, delayed cell death (terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling and cleaved caspase 3) and microglial ramification (ionized calcium-binding adapter molecule 1) were evaluated. RESULTS: At 48 hours after hypoxia-ischemia, substantial cerebral injury was found in the normothermia and 30°C hypothermia groups. However, with 35°C and 33.5°C cooling, a clear reduction in delayed cell death and microglial activation was observed in most brain regions (P<0.05), with no differences between 35°C and 33.5°C cooling groups. A protective pattern was observed, with U-shaped temperature dependence in delayed cell death in periventricular white matter, caudate nucleus, putamen, hippocampus, and thalamus. A microglial activation pattern was also seen, with inverted U-shaped temperature dependence in periventricular white matter, caudate nucleus, internal capsule, and hippocampus (all P<0.05). CONCLUSIONS: Cooling to 35°C (an absolute drop of 3.5°C as in therapeutic hypothermia protocols) or to 33.5°C provided protection in most brain regions after a cerebral hypoxic-ischemic insult in the newborn piglet. Although the relatively wide therapeutic range of a 3.5°C to 5°C drop in temperature reassured, overcooling (an 8.5°C drop) was clearly detrimental in some brain regions.
BACKGROUND AND PURPOSE: In infants with moderate to severe neonatal encephalopathy, whole-body cooling at 33°C to 34°C for 72 hours is standard care with a number needed to treat to prevent a adverse outcome of 6 to 7. The precise brain temperature providing optimal neuroprotection is unknown. METHODS: After a quantified global cerebral hypoxic-ischemic insult, 28 piglets aged <24 hours were randomized (each group, n=7) to (1) normothermia (38.5°C throughout) or whole-body cooling 2 to 26 hours after insult to (2) 35°C, (3) 33.5°C, or (4) 30°C. At 48 hours after hypoxia-ischemia, delayed cell death (terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling and cleaved caspase 3) and microglial ramification (ionized calcium-binding adapter molecule 1) were evaluated. RESULTS: At 48 hours after hypoxia-ischemia, substantial cerebral injury was found in the normothermia and 30°C hypothermia groups. However, with 35°C and 33.5°C cooling, a clear reduction in delayed cell death and microglial activation was observed in most brain regions (P<0.05), with no differences between 35°C and 33.5°C cooling groups. A protective pattern was observed, with U-shaped temperature dependence in delayed cell death in periventricular white matter, caudate nucleus, putamen, hippocampus, and thalamus. A microglial activation pattern was also seen, with inverted U-shaped temperature dependence in periventricular white matter, caudate nucleus, internal capsule, and hippocampus (all P<0.05). CONCLUSIONS: Cooling to 35°C (an absolute drop of 3.5°C as in therapeutic hypothermia protocols) or to 33.5°C provided protection in most brain regions after a cerebral hypoxic-ischemic insult in the newborn piglet. Although the relatively wide therapeutic range of a 3.5°C to 5°C drop in temperature reassured, overcooling (an 8.5°C drop) was clearly detrimental in some brain regions.
Authors: Denis V Azzopardi; Brenda Strohm; A David Edwards; Leigh Dyet; Henry L Halliday; Edmund Juszczak; Olga Kapellou; Malcolm Levene; Neil Marlow; Emma Porter; Marianne Thoresen; Andrew Whitelaw; Peter Brocklehurst Journal: N Engl J Med Date: 2009-10-01 Impact factor: 91.245
Authors: Seetha Shankaran; Abbot R Laptook; Athina Pappas; Scott A McDonald; Abhik Das; Jon E Tyson; Brenda B Poindexter; Kurt Schibler; Edward F Bell; Roy J Heyne; Claudia Pedroza; Rebecca Bara; Krisa P Van Meurs; Cathy Grisby; Carolyn M Petrie Huitema; Meena Garg; Richard A Ehrenkranz; Edward G Shepherd; Lina F Chalak; Shannon E G Hamrick; Amir M Khan; Anne Marie Reynolds; Matthew M Laughon; William E Truog; Kevin C Dysart; Waldemar A Carlo; Michele C Walsh; Kristi L Watterberg; Rosemary D Higgins Journal: JAMA Date: 2014 Dec 24-31 Impact factor: 56.272
Authors: Aron Kerenyi; Dorottya Kelen; Stuart D Faulkner; Alan Bainbridge; Manigandan Chandrasekaran; Ernest B Cady; Xavier Golay; Nicola J Robertson Journal: Pediatr Res Date: 2012-02-07 Impact factor: 3.756
Authors: Thomas Wood; Catherine Hobbs; Mari Falck; Anne Charlotte Brun; Else Marit Løberg; Marianne Thoresen Journal: Pediatr Res Date: 2017-11-01 Impact factor: 3.756
Authors: Jeeun Kang; Emad M Boctor; Shawn Adams; Ewa Kulikowicz; Haichong K Zhang; Raymond C Koehler; Ernest M Graham Journal: J Appl Physiol (1985) Date: 2018-06-21
Authors: Emmett E Whitaker; Christopher Z Zheng; Bruno Bissonnette; Andrew D Miller; Tanner L Koppert; Joseph D Tobias; Christopher R Pierson; Fedias L Christofi Journal: J Vis Exp Date: 2017-06-11 Impact factor: 1.355
Authors: Yury S Tarahovsky; Irina S Fadeeva; Natalia P Komelina; Maxim O Khrenov; Nadezhda M Zakharova Journal: Psychopharmacology (Berl) Date: 2016-12-08 Impact factor: 4.530
Authors: Kathryn A Martinello; Christopher Meehan; Adnan Avdic-Belltheus; Ingran Lingam; Tatenda Mutshiya; Qin Yang; Mustafa Ali Akin; David Price; Magdalena Sokolska; Alan Bainbridge; Mariya Hristova; Ilias Tachtsidis; Cally J Tann; Donald Peebles; Henrik Hagberg; Tim G A M Wolfs; Nigel Klein; Boris W Kramer; Bobbi Fleiss; Pierre Gressens; Xavier Golay; Nicola J Robertson Journal: Pediatr Res Date: 2021-05-28 Impact factor: 3.953
Authors: Seetha Shankaran; Abbot R Laptook; Athina Pappas; Scott A McDonald; Abhik Das; Jon E Tyson; Brenda B Poindexter; Kurt Schibler; Edward F Bell; Roy J Heyne; Claudia Pedroza; Rebecca Bara; Krisa P Van Meurs; Carolyn M Petrie Huitema; Cathy Grisby; Uday Devaskar; Richard A Ehrenkranz; Heidi M Harmon; Lina F Chalak; Sara B DeMauro; Meena Garg; Michelle E Hartley-McAndrew; Amir M Khan; Michele C Walsh; Namasivayam Ambalavanan; Jane E Brumbaugh; Kristi L Watterberg; Edward G Shepherd; Shannon E G Hamrick; John Barks; C Michael Cotten; Howard W Kilbride; Rosemary D Higgins Journal: JAMA Date: 2017-07-04 Impact factor: 56.272